Dimensional Fund Advisors
ICPT

Dimensional Fund Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Dimensional Fund Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-43,092
Closed -$7.09M – 3307
2016
Q3 		$7.09M Buy
43,092
+12,343
+40% +$1.95M ﹤0.01% 2384
2016
Q2 		$4.39M Buy
+30,749
New +$4.48M ﹤0.01% 2546
2016
Q1 		– Sell
-36,610
Closed -$5.47M – 3314
2015
Q4 		$5.47M Buy
36,610
+578
+2% +$97.8K ﹤0.01% 2474
2015
Q3 		$5.97M Buy
36,032
+9,443
+36% +$2.08M ﹤0.01% 2436
2015
Q2 		$6.42M Buy
26,589
+24,985
+1,558% +$6.65M ﹤0.01% 2475
2015
Q1 		$456K Buy
1,604
+914
+132% +$198K ﹤0.01% 3121
2014
Q4 		$108K Sell
690
-6,003
-90% -$1.11M ﹤0.01% 3309
2014
Q3 		$1.59M Buy
6,693
+4,324
+183% +$1.1M ﹤0.01% 2900
2014
Q2 		$563K Buy
2,369
+1,069
+82% +$282K ﹤0.01% 3166
2014
Q1 		$429K Buy
+1,300
New +$439K ﹤0.01% 3217

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Dimensional Fund Advisors's ICPT Position: Q4 2016 in Review

Dimensional Fund Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2016, closing a stake of 43,092 shares — an estimated $7.09M sold.

Dimensional Fund Advisors first reported a position in ICPT in Q1 2014 and held it in 10 quarters. The position peaked at $7.09M in Q3 2016. 159 funds tracked by Wall St. Rank hold ICPT as of Q4 2016.

  • Dimensional Fund Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Dimensional Fund Advisors sold 43,092 Intercept Pharmaceuticals, Inc. shares in Q4 2016, an estimated $7.09M.
  • Dimensional Fund Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 10 quarters.
  • Dimensional Fund Advisors's Intercept Pharmaceuticals, Inc. position peaked at $7.09M in Q3 2016.
  • 159 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2016.

Based on Dimensional Fund Advisors's 13F filing for Q4 2016, filed 9 Feb 2017.